Patent details

EP2970945 Title: IMPROVED THYMIDINE KINASE GENE

Basic Information

Publication number:
EP2970945
PCT Application Number:
US2014029814
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP147693469
PCT Publication Number:
WO2014153258
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
IMPROVED THYMIDINE KINASE GENE
French Title of Invention:
GÈNE CODANT POUR DES THYMIDINE KINASES AMÉLIORÉES
German Title of Invention:
VERBESSERTES THYMIDINKINASEGEN
SPC Number:

Dates

Filing date:
14/03/2014
Grant date:
01/05/2024
EP Publication Date:
20/01/2016
PCT Publication Date:
25/09/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/05/2024
EP B1 Publication Date:
01/05/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
14/03/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/04/2024
 
 

Name:
GenVivo, Inc.
Address:
475 Huntington Drive, San Marino, CA 91108, United States (US)

Inventor

1

Name:
LEVY, John, P.
Address:
United States (US)

2

Name:
REED, Rebecca, A.
Address:
United States (US)

3

Name:
MCNULTY, Joseph
Address:
United States (US)

4

Name:
JOHNSON, Robert, G.
Address:
United States (US)

Priority

Priority Number:
201361784901 P
Priority Date:
14/03/2013
Priority Country:
United States (US)

Classification

IPC classification:
A01N 63/00; A61K 48/00; A61K 49/00; C12N 15/00; A61K 31/522; A61K 31/713; C07K 14/005; C12N 9/12;

Publication

European Patent Bulletin

Issue number:
202418
Publication date:
01/05/2024
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/09/2025
Annual Fee Number:
12
Annual Fee Amount:
165 Euro
Penalty Fee Amount:
20 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages